These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 22289176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins.
    Chen H, Lin YW, Mao YQ, Wu J, Liu YF, Zheng XY, Xie LP.
    Cancer Lett; 2012 Jul 01; 320(1):40-7. PubMed ID: 22266187
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.
    Fei X, Qi M, Wu B, Song Y, Wang Y, Li T.
    FEBS Lett; 2012 Feb 17; 586(4):392-7. PubMed ID: 22265971
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
    Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, Akao Y.
    Cancer Lett; 2013 Jan 28; 328(2):353-61. PubMed ID: 23104321
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
    Lin Y, Chen H, Hu Z, Mao Y, Xu X, Zhu Y, Xu X, Wu J, Li S, Mao Q, Zheng X, Xie L.
    FEBS Lett; 2013 Aug 02; 587(15):2467-73. PubMed ID: 23796420
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.
    Wang X, Wu J, Lin Y, Zhu Y, Xu X, Xu X, Liang Z, Li S, Hu Z, Zheng X, Xie L.
    J Exp Clin Cancer Res; 2014 Sep 02; 33(1):69. PubMed ID: 25178497
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS, Lee WJ, Lee SW, Chae HW, Kim DH, Oh Y.
    Horm Metab Res; 2010 Mar 02; 42(3):165-72. PubMed ID: 19960406
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
    Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D, Huang Y.
    FEBS J; 2011 Mar 02; 278(5):786-92. PubMed ID: 21205209
    [Abstract] [Full Text] [Related]

  • 20. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
    Cabrita MA, Vanzyl EJ, Hamill JD, Pan E, Marcellus KA, Tolls VJ, Alonzi RC, Pastic A, Rambo TM, Sayed H, McKay BC.
    PLoS One; 2016 Mar 02; 11(2):e0148529. PubMed ID: 26840126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.